Cerus Corp Share Price

NASDAQ: CERS

Small Cap

$1.23

-0.02

(-1.60%)

as on September 13, 2025 at 1:29 am IST

$₹

Cerus Corp Stock Performance

as on September 13, 2025 at 1:29 am IST

Day's Low
Day's High
$1.21
Day's Price Range
$1.24
$1.23
1.63%
Downside
0.81%
Upside
52 Week's Low
52 Week's High
$1.12
52-Week Price Range
$2.24
$1.23
8.94%
Downside
81.71%
Upside

Cerus Corp share price movements today

Previous Close: $1.25
Open: $1.24
Volume: 610.2K
Day's Low - High: $1.21 - $1.24
52 Week Low - High: $1.12 - $2.24

Cerus Corp Historical Returns

1 Month Return: -7.52 %
3 Month Return: -6.82 %
1 Year Return: -40.58 %
3 Year Return: -68.86 %
5 Year Return: -80.06 %

Cerus Corp Stock Fundamentals & Key Indicators

Check Cerus Corp market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$235.8M

EPS (TTM)

-0.105

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-17.64

Industry PE ratio

-3.773885542168675

P/B Ratio

PEG Ratio

EBITDA

-10.3M

Revenue (TTM)

192.5M

Profit Margin

-9.81%

Return On Equity TTM

77494500.00%

Cerus Corp Stock Valuation

Track how Cerus Corp P/E has moved over time to understand its valuation trends.

Cerus Corp in the last 5 years

Overview
Trends

Lowest (0.00x)

September 13, 2025

Today (-17.64x)

September 13, 2025

Industry (-3.77x)

September 13, 2025

Highest (0.00x)

September 13, 2025

LowHigh

Today’s Price to Earnings Ratio: -17.64x

Cerus Corp vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Cerus Corp with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Cerus Corp	BUY	$235.8M	-80.06%	-17.64	-9.81%
Boston Scientific Corp.	BUY	$152.2B	154.93%	61.14	13.55%
Stryker Corporation	BUY	$146.6B	89.75%	50.77	12.25%
Abbott Laboratories	BUY	$232.8B	27.73%	16.78	32.43%
Medtronic Plc	BUY	$120.6B	-10.25%	25.98	13.63%

See all

Stock Returns calculator for Cerus Corp Stock including INR - Dollar returns

The Cerus Corp stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Cerus Corp investment value today

Current value as on today

₹64,559

Returns

₹35,441

(-35.44%)

Returns from Cerus Corp Stock

₹40,580 (-40.58%)

Dollar Returns*

₹5,139 (+5.14%)

Analyst Recommendation on Cerus Corp Stock

Based on 12 analysts

BUY

75.00%

Buy

25.00%

Hold

0.00%

Sell

Based on 12 analysts, 75% of analysts recommend a 'BUY' rating for Cerus Corp. Average target price of $4.67

Cerus Corp Share Price Target

Get share price movements and forecasts by analysts on Cerus Corp.

What analysts predicted

73.66%UPSIDE

Target Price

$4.67

Current Price

$1.23

Analyzed by

12 Analysts

Target

$4.67

Cerus Corp target price $4.67, a slight upside of 73.66% compared to current price of $1.23. According to 12 analysts rating.

Cerus Corp Stock's Interest Amongst Investors

Search interest for Cerus Corp Stock has decreased by -36% in the last 30 days, reflecting a downward trend in search activity.

Time period: August 16, 2025 to September 15, 2025

Change:-36% versus previous 30 day period

Cerus Corp Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Total Revenue	30	38	39	46	38	45	46	50	43	52
Gross Profit	17	21	21	25	21	24	26	27	25	28
Operating Income	-14	-11	-5	-5	-13	-9	0	-1	-5	-3
EBITDA	-13	-9	-4	1	-6	-3	0	0	-5	-3
Interest Expense	1	2	2	2	2	2	2	2	2	2
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-15	-13	-7	-1	-9	-5	-2	-2	-7	-5
Income Tax Expense	0	0	0	0	0	0	0	0	0	0
Net Income	-15	-13	-7	-1	-9	-5	-2	-2	-7	-5
Net Profit Margin	-50.50%	-34.17%	-18.27%	-2.84%	-25.25%	-12.81%	-6.38%	-4.96%	-17.85%	-10.88%

Cerus Corp Annual Profit & Loss

All numbers in Millions USD

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	34	37	43	60	74	91	130	162	156	180
Gross Profit	10	16	21	29	41	50	67	87	86	99
Operating Income	-61	-61	-57	-54	-66	-58	-48	-34	-30	-14
EBITDA	-56	-58	-51	-53	-63	-55	-45	-31	-26	-9
Interest Expense	1	2	3	4	6	3	4	5	8	8
Depreciation	-	-	1	1	2	3	3	2	2	1
Income Before Tax	-59	-62	-56	-57	-70	-59	-54	-42	-37	-20
Income Tax Expense	-3	0	3	0	0	0	0	0	0	0
Net Income	-55	-62	-60	-57	-71	-59	-54	-42	-37	-20
Net Profit Margin	-163.25%	-169.18%	-139.06%	-94.51%	-95.44%	-65.12%	-41.55%	-26.43%	-23.98%	-11.60%

Cerus Corp Quarterly Cash Flow

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Net Income	-13	-7	-1	-9	-5	-2	-2	-7	-5
Operating Cash Flow	-8	-10	-15	1	0	4	4	0	-2
Investing Cash Flow	2	0	8	1	-7	4	-7	-1	-1
Financing Cash Flow	0	7	1	5	-1	0	0	1	0
Change in Cash	-6	-3	-5	8	-8	9	-1	0	-3

Cerus Corp Annual Cash Flow

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	-62	-60	-57	-71	-59	-54	-42	-37	-20
Operating Cash Flow	-53	-52	-31	-65	-40	-33	-25	-43	11
Investing Cash Flow	-19	0	-43	28	-49	12	8	8	-8
Financing Cash Flow	24	43	92	43	91	34	4	10	4
Change in Cash	-48	-8	17	5	1	12	-13	-23	8

Global Institutional Holdings in Cerus Corp

Funds	Holdings
Baker Bros Advisors LP	10.09%
ARK Investment Management LLC	10.02%
BlackRock Inc	7.77%
Vanguard Group Inc	5.51%
Wasatch Advisors LP	4.34%

See all

Insights on Cerus Corp

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 2 quarters, -7.71M → -5.70M (in $), with an average increase of 35.2% per quarter
POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 2 quarters, 43.23M → 52.44M (in $), with an average increase of 17.6% per quarter
NO EFFECT
Against Peers
In the last 3 years, Boston Scientific Corp. has given 143.4% return, outperforming this stock by 212.6%
NO EFFECT
Against Peers
In the last 1 year, Boston Scientific Corp. has given 23.3% return, outperforming this stock by 63.6%
NEGATIVE IMPACT
Price Dip
In the last 7 days, CERS stock has moved down by -5.0%

About Cerus Corp

cerus corporation is a biomedical products company focused on commercializing the intercept blood system to enhance blood safety. the intercept system is designed to reduce the risk of transfusion-transmitted diseases by inactivating a broad range of pathogens such as viruses, bacteria and parasites that may be present in donated blood. the nucleic acid targeting mechanism of action enables intercept treatment to inactivate established transfusion threats, such as hepatitis b and c, hiv, west nile virus and bacteria, and is designed to inactivate emerging pathogens such as influenza, malaria and dengue. cerus currently markets and sells the intercept blood system for both platelets and plasma in europe, russia, the middle east and selected countries in other regions around the world. the intercept red blood cell system is in clinical development.

Organisation	Cerus Corp
Headquarters	1220 Concord Avenue, Concord, CA, United States, 94520
Industry	Health Technology
CEO	Mr. William M. Greenman
E-voting on shares	Click here to vote

Key Management of Cerus Corp

Name	Title
Ms. Chrystal N. Jensen J.D.	Chief Legal Officer, General Counsel & Secretary
Dr. Nina Mufti Ph.D.	Senior Vice President of Research & Development
Ms. Jessica Hanover Ph.D.	Vice President of Corporate Affairs
Mr. William M. Greenman	President, CEO & Chairman
Mr. Vivek K. Jayaraman	Chief Operating Officer
Dr. Richard J. Benjamin MBChB, Ph.D.	Chief Medical Officer
Dr. Laurence M. Corash M.D.	Co-Founder & Chief Scientific Officer
Lainie Corten	Vice President of Global Marketing
Ms. Carol M. Moore	Senior Vice President of Regulatory Affairs, Quality & Clinical
Mr. Kevin D. Green CPA	VP of Finance & CFO

FAQs

What is Cerus Corp share price today?

Cerus Corp share price today is $1.23 as on September 13, 2025 at 1:29 am IST at the close of the market. Cerus Corp share today touched a day high of $1.24 and a low of $1.21.

What is the 52 week high and 52 week low for Cerus Corp share?

Cerus Corp share touched a 52 week high of $2.24 on January 28, 2025 and a 52 week low of $1.12 on April 7, 2025. Cerus Corp stock price today i.e. September 13, 2025 at 1:29 am IST is closed at $1.23,which is 44.97% down from its 52 week high and 9.82% up from its 52 week low.

What is Cerus Corp's market capitalisation today?

Cerus Corp market capitalisation is $0.00T as on September 13, 2025 at 1:29 am IST.

How to invest in Cerus Corp Stock (CERS) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Cerus Corp on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Cerus Corp Shares that will get you 1.2195 shares as per Cerus Corp share price of $1.23 per share as on September 13, 2025 at 1:29 am IST.

What is the minimum amount required to buy Cerus Corp Stock (CERS) from India?

Indian investors can start investing in Cerus Corp (CERS) shares with as little as ₹88.27 or $1 (as of September 15, 2025 at 7:40 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹882.70 in Cerus Corp stock (as per the Rupee-Dollar exchange rate as on September 15, 2025 at 7:40 am IST). Based on Cerus Corp share’s latest price of $1.23 as on September 13, 2025 at 1:29 am IST, you will get 8.1301 shares of Cerus Corp. Learn more about fractional shares .

What are the returns that Cerus Corp has given to Indian investors in the last 5 years?

Cerus Corp stock has given -80.06% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?